The aim of the NOCA is to evaluate the patterns of care and outcomes for patients with ovarian cancer in England and Wales.
A huge thank you to all the trusts who have responded!
Find more details here on responses so far : buff.ly/AyiWGrc
A huge thank you to all the trusts who have responded!
Find more details here on responses so far : buff.ly/AyiWGrc
Learn more about ovarian cancer and key findings about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/x99UfX3
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
Learn more about ovarian cancer and key findings about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/x99UfX3
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
She shared insights on the NOCA State of the Nation report and upcoming QI Intervention.
Missed it? Catch up here: buff.ly/RsaLo4B
She shared insights on the NOCA State of the Nation report and upcoming QI Intervention.
Missed it? Catch up here: buff.ly/RsaLo4B
Thanks to NOCA Clinical Fellow, Dr Georgia Zachou, who shared valuable insights on the NOCA report.
Missed it? Catch up here: buff.ly/OQMK5q6
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
Thanks to NOCA Clinical Fellow, Dr Georgia Zachou, who shared valuable insights on the NOCA report.
Missed it? Catch up here: buff.ly/OQMK5q6
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
buff.ly/C2XYSW7
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
buff.ly/C2XYSW7
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Read about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/dOTZClC
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Read about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/dOTZClC
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Great to see such strong engagement from the gynae-oncology community! 🙌
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Great to see such strong engagement from the gynae-oncology community! 🙌
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Explore the latest data insights and performance indicator updates.
🔗 buff.ly/nkA9hR6
@natcan-news.bsky.social @targetovarian.bsky.social
Explore the latest data insights and performance indicator updates.
🔗 buff.ly/nkA9hR6
@natcan-news.bsky.social @targetovarian.bsky.social